Pls refer the attachment
VIJAYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Vijaya Diagnostic Centre's Board approved Q4 and FY2026 audited financial results and recommended a final dividend of ₹2 per share (200% on ₹1 face value), subject to shareholder approval at the upcoming AGM. The Board also decided not to seek re-appointment of Dr. D Nageshwar Reddy as Independent Director after his first term ends on May 25, 2026, citing his pre-occupation and other professional commitments. Additionally, the company granted 1,79,500 ESOPs to eligible employees at ₹784 per option (20% discount to 3-month average price) under the VDCL Employee Stock Option Plan 2018. The Board approved acquisition of MRI, EEG and NCV services business from its wholly-owned subsidiary Medinova Millennium MRI Services LLP for approximately ₹4.20 crore in cash, with the transaction classified as a related party transaction.
The dividend recommendation signals confidence in financial health, while the ESOP grant aligns employee interests with shareholders. The related party acquisition of the subsidiary's business may attract regulatory scrutiny despite being an intra-group restructuring.